Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Department of Surgical Oncology, Brigham and Women's Hospital, Boston, MA, USA.
Ann Surg Oncol. 2020 Feb;27(2):367-372. doi: 10.1245/s10434-019-07704-1. Epub 2019 Aug 9.
There is limited data evaluating mastectomy skin flap complications of nipple-sparing mastectomy (NSM) in patients with BRCA gene mutations. The purpose of this study was to identify factors associated with post-operative complications in BRCA mutation carriers undergoing NSM.
Following institutional review board approval, we interrogated a prospectively collected institutional database for patients undergoing NSM who tested positive for BRCA1/2 mutations. Patient characteristics, preoperative details, and complications were evaluated. Digital mammogram was used to estimate the breast volume.
From August 2009 to December 2017, 59 patients (2 males) with BRCA1/2 mutations underwent 114 NSMs. Ninety-two (80%) were risk-reduction surgeries. Thirty-two (28%) underwent single-stage reconstruction (24 autologous). The overall complication rate was 26.3% (N = 30), and 10.5% (N = 12) underwent unanticipated reoperation. 8.8% (N = 10) had full-thickness skin flap necrosis, 10.5% (N = 12) nipple necrosis, and 4.4% (N = 5) full-thickness nipple necrosis. These complications were associated with larger breast volume (799.4 cc vs. 544.1 cc, p < 0.001) and greater body mass index (27.8 vs. 24.3, p < 0.001). By univariate analysis, body mass index and breast volume greater than 675 cc were associated with significantly higher complication rate (odds ratios 1.2 and 4.5 respectively, p = 0.001).
This study confirms that NSM in BRCA1/2 mutation carriers is associated with complications in one in four patients. Utilizing the preoperative mammograms to estimate breast size may be more helpful than breast cup size in counseling preoperatively the risks of complications.
在携带 BRCA 基因突变的患者中,保乳乳房切除术(NSM)的乳房皮瓣并发症的数据有限。本研究的目的是确定接受 NSM 的 BRCA 基因突变携带者术后并发症的相关因素。
经机构审查委员会批准,我们从一个前瞻性收集的机构数据库中查询了 BRCA1/2 突变阳性的接受 NSM 的患者。评估了患者特征、术前细节和并发症。数字乳房 X 线照片用于估计乳房体积。
从 2009 年 8 月至 2017 年 12 月,59 名(2 名男性)携带 BRCA1/2 突变的患者接受了 114 例 NSM。92 例(80%)为降低风险手术。32 例(28%)进行了单阶段重建(24 例为自体)。总的并发症发生率为 26.3%(N=30),10.5%(N=12)需要意外再次手术。8.8%(N=10)发生全层皮瓣坏死,10.5%(N=12)乳头坏死,4.4%(N=5)全层乳头坏死。这些并发症与更大的乳房体积(799.4cc 比 544.1cc,p<0.001)和更大的体重指数(27.8 比 24.3,p<0.001)相关。单因素分析显示,体重指数和乳房体积大于 675cc 与并发症发生率显著升高相关(比值比分别为 1.2 和 4.5,p=0.001)。
本研究证实,在携带 BRCA1/2 突变的患者中,NSM 与四分之一患者的并发症相关。利用术前乳房 X 光片估计乳房大小可能比乳房罩杯大小更有助于术前评估并发症风险。